Veterinary Vaccination is the medication given to the animals which enhances their health as well as improving their life time. These vaccinations prevent diseases like foot-and-mouth disease, influenza etc which generally affect livestock leading to their death. These deaths cause huge economic losses across the globe. The Global Veterinary Vaccines Market was worth 6.37 Billion USD in 2018 and is estimated to reach 9.61 Billion USD by 2025 at a CAGR of 6.05% during the forecast period.
Drivers vs. Constraints
Increasing occurrences of veterinary diseases among animals is the key factor for the growth of Global Veterinary Vaccines Market. Rise in the number of pet owners and change in the life styles also help in the growth of this market.
Industry Structure and Updates
In the motive to excel in the Veterinary Vaccines market Pfizer had acquired Wyeth which is said to be the largest acquisition.
Global Veterinary Vaccines Market – by Type, Product, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2018 - 2025)
1. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Definition
3.2. Industry Value Chain Analysis
3.3. Porter's 5 Forces
3.4. Regulations
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends
5. Global Veterinary Vaccines Market Segmentation, Forecasts and Trends - by Type
5.1. Porcine Vaccines
5.2. Poultry Vaccines
5.3. Livestock Vaccines
5.3.1. Bovine Vaccines
5.3.2. Small Ruminant Vaccines
5.4. Companion Animal Vaccines
5.4.1. Canine Vaccines
5.4.2. Feline Vaccines
5.5. Aquaculture Vaccines
5.6. Other Animal Vaccines
6. Global Veterinary Vaccines Market Segmentation, Forecasts and Trends - by Product
6.1. Attenuated Live Vaccines
6.2. Inactivated Vaccines
6.3. Subunit Vaccines
6.4. DNA Vaccines
6.5. Recombinant Vaccines
6.6. Others
7. Global Veterinary Vaccines Market Segmentation, Forecasts and Trends - by Region
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.3. Mexico
7.2. Europe
7.2.1. UK
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Others
7.3. Asia Pacific
7.3.1. India
7.3.2. China
7.3.3. Japan
7.3.4. Australia
7.3.5. Others
7.4. South America
7.4.1. Brazil
7.4.2. Argentina
7.4.3. Others
7.5. Middle East and Africa
7.5.1. South Africa
7.5.2. UAE
7.5.3. Saudi Arabia
7.5.4. Egypt
7.5.5. Others
8. Competitive Intelligence
8.1. Company Market Share Analysis
8.2. Industry M&As, Consolidations
9. Company Profiles
9.1. Bayer Healthcare
9.2. Boehringer Ingelheim
9.3. Ceva Animal Health, Inc.
9.4. Elanco
9.5. Merck
9.6. Merial (Sanofi)
9.7. Zoetis
9.8. Virbac Inc.
9.9. Biogenesis Bago S.A.
9.10. Indian Immunological Limited
9.11. Heska Corporation
9.12. Bimeda
9.13. Phibro Animal Health
9.14. Vetoquinol
9.15. Hester
9.16. Hipra
9.17. IDT Biologika
9.18. China Animal Husbandry
9.19. Jinyu Bio-technology
9.20. Others
10. Investment Opportunities